• Nutrition Research and Practice
• /
• 제4권6호
• /
• pp.486-491
• /
• 2010

Tight control of blood glucose is the most important strategy for the treatment of diabetes mellitus. Here, we investigated the beneficial effects of Welsh onion on fasting and postprandial hyperglycemia. Inhibitory activities of hot water extracts from the green stalk and white bulb, which are the edible portions of the Welsh onion, and the fibrous root extract against yeast ${\alpha}$-glucosidase were measured in vitro. To study the effects of Welsh onion on postprandial hyperglycemia, a starch solution (1 g/kg) with and without Welsh onion fibrous root extract (500 mg/kg) or acarbose (50 mg/kg) was administered to streptozotocin-induced diabetic rats after an overnight fast. Postprandial plasma glucose levels were measured and incremental areas under the response curve were calculated. To study the hypoglycemic effects of chronic feeding of Welsh onion, five-week-old db/db mice were fed an AIN-93G diet or a diet containing either Welsh onion fibrous root extract at 0.5% or acarbose at 0.05% for 7 weeks after 1 week of adaptation. Fasting plasma glucose and blood glycated hemoglobin were measured. Compared to the extract from the edible portions of Welsh onion, the fibrous root extract showed stronger inhibition against yeast ${\alpha}$-glucosidase, with an $IC_{50}$ of 239 ${\mu}g/mL$. Oral administration of Welsh onion fibrous root extract (500 mg/kg) and acarbose (50 mg/kg) significantly decreased incremental plasma glucose levels 30-120 min after oral ingestion of starch as well as the area under the postprandial glucose response curve, compared to the control group (P < 0.01). The plasma glucose and blood glycated hemoglobin levels of the Welsh onion group were significantly lower than those of the control group (P < 0.01), and were not significantly different from those fed acarbose. Thus, we conclude that the fibrous root of Welsh onion is effective in controlling hyperglycemia in animal models of diabetes mellitus.

• 한국식품영양과학회지
• /
• 제36권10호
• /
• pp.1257-1262
• /
• 2007

혈당강하 효능을 갖는 버섯배양곡물을 개발하기 위하여 수종의 버섯균과 버섯배양곡물의 식후 혈당상승 억제 효과를 조사하였다. 균사체의 포도당 투과지연 효과를 측정한 결과 120분 동안 투석후 전체 포도당 중 $13.1{\pm}3.6{\sim}41.8{\pm}8.0%$의 포도당이 투석막 내액에 잔존하는 것으로 나타나 대부분의 균사체가 pectin보다 포도당의 투석막 밖으로의 투과를 지연시키는 효과가 컸다. 당뇨쥐에 균사체를 투여한 후 혈당변화를 조사한 결과 맥아당 섭취후 30분 경과시 $389.4{\pm}43.8{\sim}426.3{\pm}49.4mg/dL$로 대조구의 $535.3{\pm}78.6mg/dL$에 비해 상당히 낮은 값을 나타내어 버섯균사체의 식후 혈당상승 억제 효과가 우수한 것으로 나타났으며, 특히 Phellinus linteus와 Paecilomyces japonica의 효과가 우수하였다. Paecilomyces japonica를 배양한 버섯배양곡물을 당뇨쥐에 투여한 후 혈당변화를 조사한 결과 버섯 균사를 배양하지 않은 곡물에 비해 현저히 낮은 식후 혈당상승을 나타내어 버섯배양곡물이 우수한 혈당강하 효능을 나타냄을 알 수 있었고 특히 버섯배양 보리의 효과가 큰 것으로 나타났다.

• Food Science and Biotechnology
• /
• 제15권3호
• /
• pp.413-417
• /
• 2006

The purpose of this study was to investigate the hypoglycemic effect of Saururus chinensis Baill in vitro and in vivo. Methanol extract of S. chinensis Baill inhibited yeast ${\alpha}$-glucosidase activity by 49.8%, which was twice as strong as that of acarbose at a concentration of 0.5 mg/mL in vitro. The effect of S. chinensis Baill methanol extract on the postprandial increase in blood glucose levels was studied in streptozotocin-induced diabetic rats using a carbohydrate load test. Oral administration of S. chinensis Baill extract (500 mg/kg) significantly decreased incremental blood glucose levels at 60 and 90 min (p<0.05) after oral ingestion of starch (1 g/kg). The area under the glucose response curve of the S. chinensis Baill group was significantly decreased compared to that of the control group (p<0.05). The effect of prolonged feeding of S. chinensis Baill was studied in an animal model of type 2 diabetes. Three-week-old db/db mice were fed an AIN-93G diet or a diet containing 0.5% S. chinensis Baill extract for 7 weeks after 1 week of adaptation. Plasma glucose, insulin, and blood glycated hemoglobin levels of the mice fed S. chinensis Baill extract were significantly lower than those of the control group (p<0.05). Therefore, we conclude that S. chinensis Baill is effective in controlling hyperglycemia in animal models of diabetes mellitus.